FDA needs to take further action on e-cigarettes

While the American Thoracic Society appreciates that the FDA took action on certain flavored cartridge-based vaping products, it is disappointed that the Administration chose to not follow through on its September 2019 promise to clear the market of all flavored electronic nicotine delivery projects.

The fact that youth e-cigarette use grew by nearly 40 percent in one year should make preventing children from being able to access all vaping products an immediate priority. We continue to urge Congress to pass legislation that bans all e-cigarette flavors, including menthol for all e-cigarette products and not just pod cartridges.

It is amazing how in a few short weeks, the FDA went from 'clearing the market of all flavored products' to effectively clearing the market for Juul's menthol e-cigarettes and flavored e-liquids for 'tank' vaping systems."

Michelle Eakin, PhD., ATS Tobacco Action Committee Chair

This policy will also allow flavorings to continue to be on the market for non-pod devices which will result in thousands of kid-friendly e-liquids to continue to be available. While there is substantial evidence that e-cigarette flavorings are linked to higher rates of initiation and transition to daily use, there is no credible evidence demonstrating flavorings help adults quit tobacco product use.

Overall, this policy will not stop the youth e-cigarette epidemic. "I will leave it to others to speculate why the FDA has so quickly changed its mind," said Dr. Eakin. "Regardless, leaving menthol e-cigs on the market is good for the vaping industry and bad for kids."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals the power of sleep in enhancing motor learning for individuals with brain injury